Covered on earnings — but the price just fell 22% in a day. A $0.30 quarterly dividend at a 67.14% trailing payout, flat since November 2023. The 6.89% yield arrived the hard way — the price fell 22.47% on October 23, 2026 — and first-half 2026 free cash flow was negative at −$36 million while the board runs a strategic review that includes a possible sale of the whole company.
Key risk: The strategic review could end in a sale, and Europe's ERP transition plus weak UK/Benelux demand are already hurting revenue.
Changes if: Free cash flow stays negative for another half, or the review ends in a breakup.
- ✓Earnings cover 67.14% trailing payout, per StockAnalysis.
- !Cash-flow cover H1 2026 free cash flow −$36M; Q2 alone was +$60M.
- !Price-collapse yield 6.89% after a 22.47% single-day fall on Oct 23, 2026.
- !Strategic review Board review since January 2026 includes a possible sale of the company.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.